Success Stories: North America Immigration Law Group Aided a Postdoctoral Fellow Obtain EB-1B Approval in Only 4 days in the Field of Molecular Biology

 


On September 22nd, 2023, we received another EB-1B (Outstanding Professors and Researchers) approval for a Postdoctoral Fellow in the Field of Molecular Biology (Approval Notice).


General Field: Molecular Biology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: China

State of Residence at the Time of Filing: Texas

Approval Notice Date: September 22nd, 2023

Processing Time: 4 days (Premium Processing Requested)


Case Summary:

After receiving an NIW approval in 2021 with our hardworking team's assistance, a postdoctoral fellow hired North America Immigration Law Group to put together an EB-1B (Outstanding Professors and Researchers) petition on his behalf. His research focused on studying the structural properties and function of biomacromolecules, addressing some of our nation’s most pressing issues in terms of comprehending the role of biomacromolecules in infectious diseases like tuberculosis and neurological and mental disorders like obesity and Alzheimer's. Also, we discovered that for the past seven years, he has been conducting molecular biology research. We received a letter from his current company attesting to his responsibilities and the dates of his employment as proof that he has at least three years of research expertise. In these letters, his function as a researcher was also explicitly discussed.

Thus, we deduced that applications of his work include figuring out the biochemical mechanisms underlying obesity, mental illnesses, and bacterial infections, which help patients in the US and around the world receive the best care possible, and we agreed to showcase the pivotal role he has played in advancing his research endeavor to the advancement of molecular biology. His EB1B petition packet consisted of the following details:

  • We noted that he possesses a record of published works in the field of molecular biology. His study has produced at least 8 peer-reviewed scientific articles, which is proof of its success. His work has been published in highly regarded, widely read molecular biology journals worldwide. Additionally, he has received widespread recognition for his articles with 75 citations. This is enough evidence to support the significance of his published body of work.
  • Also, we have provided documentation confirming his responsibilities as a peer reviewer to meet the criterion. He has conducted at least 27 peer reviews to date. These records, along with other objective evidence, demonstrate his genuine and active involvement in evaluating the work of other subject-matter experts. Expert remarks validate his peer-reviewed efforts. Therefore, we submitted evidence of 4 recommendation letters from experts in the field testifying to the significance of our client’s research contributions.
One of them stated the following:

“[Client's] superior acumen in an array of specialized topics and skills make him a unique and authoritative contributor to molecular biology. He has deep expertise in structural biology, genetics, cell biology, biochemistry, biophysics, and a wide variety of germane experimental methodologies. While he has applied his expertise across molecular biology to conduct epidemiological research that facilitates better diagnostics and treatments, especially important given the continued prevalence of TB in the world, his work in the neuroscience field is equally impactful. Allowing him to continue his research will improve public health around the world.”

Moreover, funding support from the Chinese Academy of Sciences, China's National Natural Science Foundation, the National Key Research & Development Program, and the Special Fund for Public Welfare Research and Capacity Building in Guangdong Province have all contributed to our client’s work. This funding serves as clear evidence of the merit of his work in furthering the knowledge of neurodegenerative disorders and working towards a more effective form of treatment.

Successfully, after upgrading his case to the premium processing service and our unrelenting focus, our client was able to secure his EB1B approval in just 4 days. We would thus like to thank him for his trust in our law firm and wish him luck in all of his future endeavors.